Boston Scientific
788 hedge funds and large institutions have $49B invested in Boston Scientific in 2019 Q1 according to their latest regulatory filings, with 115 funds opening new positions, 301 increasing their positions, 248 reducing their positions, and 51 closing their positions.
125% more first-time investments, than exits
New positions opened: 115 | Existing positions closed: 51
121% more call options, than puts
Call options by funds: $143M | Put options by funds: $64.6M
21% more repeat investments, than reductions
Existing positions increased: 301 | Existing positions reduced: 248
9% more capital invested
Capital invested by funds: $44.9B → $49B (+$4.1B)
8% more funds holding
Funds holding: 730 → 788 (+58)
0.3% less ownership
Funds ownership: 92.18% → 91.89% (-0.3%)
25% less funds holding in top 10
Funds holding in top 10: 20 → 15 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TP
Third Point
New York
|
+$191M |
| 2 |
A
AustralianSuper
Melbourne,
Australia
|
+$176M |
| 3 |
Bessemer Group
Woodbridge,
New Jersey
|
+$162M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$131M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$121M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$383M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$312M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$218M |
| 4 |
FAM
Fred Alger Management
New York
|
-$123M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$119M |
BSX Hedge Fund Activity: Q1 2019 in Review
788 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q1 2019, worth a combined $49B — up 9.1% from $44.9B a quarter earlier.
Buyers outnumbered sellers: 115 funds opened new BSX positions and 51 closed out — a net gain of 64 holders — while 301 added to existing stakes and 248 trimmed.
The largest buyer was Third Point, opening a new position worth an estimated $191M. The largest seller was Capital Research Global Investors, cutting an estimated $383M.
- 788 institutional investors held Boston Scientific (BSX) as of Q1 2019, up from 730 in Q4 2018.
- Funds reported $49B of Boston Scientific stock for Q1 2019, up 9.1% quarter-over-quarter.
- 115 funds opened new Boston Scientific positions in Q1 2019 and 51 closed out, a net change of +64 holders.
- The largest Boston Scientific buyer in Q1 2019 was Third Point, an estimated $191M added.
- The largest Boston Scientific seller in Q1 2019 was Capital Research Global Investors, an estimated $383M sold.
Based on aggregated 13F filings for Q1 2019.